A Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal Dysfunction

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221237

Enrollment

Registered

2010-09-10

Start date

2010-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus with renal dysfunction

Interventions

investigational material(s) Generic name etc : TS-071 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Or

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Japanese - Type 2 diabetes mellitus patient etc.

Exclusion criteria

Exclusion criteria: - Non-type 2 diabetes mellitus - Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease etc.

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026